Cancer BiologyCancer LettersPeer-reviewed
Integrative analysis of patient-derived tumoroids and ex vivo organoid modeling of ARID1A loss in bladder cancer reveals therapeutic molecular targets
Mathijs P. Scholtes, Maryam Akbarzadeh, Αλέξανδρος Γαλάρας…·Tokameh Mahmoudi
The paper identifies CHEK1 and BIRC5 as therapeutic targets in ARID1A-deficient bladder cancer using patient-derived tumoroids and public datasets.
14 citations